Interestingly, prior analyses of non-transformed EGFR-mutant NSCLC have demonstrated significantly lower rates of PIK3CA/AKT/PTEN when compared to this cohort (14.9% vs. 73%, respectively) [25]. The gene discussed is PTEN; the disease is non-small cell lung carcinoma.